Since the first emergence of the virus, Oxford Nanopore's rapid, portable sequencing technology has been used extensively for Covid-19 epidemiology and scientific research," said IP Group Chief Executive Alan Aubrey. Buy or sell Oxford Nanopore Technologies stock pre IPO via an EquityZen fund. monthly and annualsubscriptions available. IP GROUP PLC. All Rights Reserved. Versarien received orders for 120,000 of its face masks, Purplebricks shares step up on signs of housing market recovery, BBC rejects ‘nitty gritty’ complaint against Laura Kuenssberg, City workers arrested amid £6 million bounce back loan fraud probe, Covid-19: Police injured breaking up 200-strong Knightsbridge party, Snow forecast in London tomorrow as Met Office issues weather warning, Crowds at Heathrow Airport spark ‘surperspreading’ complaints, You may not agree with our views, or other users’, but please respond to them respectfully, Swearing, personal abuse, racism, sexism, homophobia and other discriminatory or inciteful language is not acceptable, Do not impersonate other users or reveal private information about third parties, We reserve the right to delete inappropriate posts and ban offending users without notification. View More Companies. View recent trades and share price information for IP Group Plc (IPO) Ord 2p Company profile page for Oxford Nanopore Technologies Ltd including stock price, company news, press releases, executives, board members, and contact information FTSE 250 firm IP Group said one of the companies in its portfolio, Oxford Nanopore Technologies, is working with the Department of Health to roll out its Lampore test. Oxford Nanopore's rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates. As per some media report, post Oxford Nanopore pitched Mr Neil Woodford, the founding partner of Woodford Investment Management, about their debut in the stock exchange within the next twelve months, the fund manager sold Nanopore's 2.15 million shares back to the company, which were then cancelled and reissued by the company as new securities. ... Buy oxford nanopore stock you can from brokers or on specialized sites. Oxford Nanopore Technologies, a UK-based genetic sequencing technology developer spun out from University of Oxford, is considering floating its shares in an initial public offering (IPO), The Telegraph has reported. With our newsletters and social media channels. IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited ("Oxford Nanopore") has announced that it has raised GBP29.3 million of new capital and facilitated the secondary sale of GBP80.2 million of shares, an aggregate investment of GBP109.5 million. Manage your personalised Watchlist.Set up an online Virtual Portfolio.Participate in Share Chat.See more trades and director dealings.Play the Fantasy Share Trading Game. View the latest IPO stock quote and chart on MSN Money. The latest IP Group Plc (IPO) Ord 2p share price (IPO). Datafeed and UK data supplied by NBTrader and Digital Look. IPO Share News. According to the article, Woodford was hoping to pay the investors of his frozen fund from IPO cash of Oxford Nanopore, but the IPO market would not accept his expected valuation of Oxford Nanopore. London Stock Exchange plc is not responsible for and does not check content on this Website. Intellectual property commercialisation company IP owns 15.8% of Oxford Nanopore, which is was spun out of the city’s university in 2005, and its shares rose 11% to 74p. ... IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress. "Oxford Nanopore has been supplying countries all over the world with sequencing capability throughout this pandemic and it's exciting to see the first diagnostic assay developed in-house, using their expertise, technology and networks to help support the response to this crisis. Source: statista.com In spring this year, the company announced to investors that it was planning a stock market listing through an IPO. Are you sure you want to delete this comment? UK WINNERS & LOSERS SUMMARY: SSE Rises On Energy-From-Waste Sale, IP Group's Oxford Nanopore Raises New Cash Amid Virus Test Progress. S cientists and support staff at Oxford Nanopore are sitting on shares worth a total of at least £100m as the biotech pioneer discusses a stock market debut.. Find the latest Oxford Immunotec Global PLC (OXFD) stock quote, history, news and other vital information to help you with your stock trading and investing. Developer of a new generation of DNA/RNA sequencing technology designed to enable the analysis of any living thing, by … Oxford Nanopore Technologies - Stock Sales | Pre-IPO Unicorn Share Secondary Prices SoFi - Buy or Sell Pre-IPO Stock or Employee and Founder Share Options SpaceX - Sale of Unicorn Private Founder | Employee and Private Company Shares Prices Oxford Nanopore in development of covid19 test . Request Access. Oxford Nanopore Technologies Stock. You can find our Community Guidelines in full here. ... IP Group says Oxford Nanopore Technologies raises £84.4m to support manufacturing push While London South East do their best to maintain the high quality of the information displayed on this site, we cannot be held responsible for any loss due to incorrect information found here. Explore our scalable DNA sequencing products and services including the portable MinION and powerful PromethION. IP Group Says Investee Oxford Nanopore Developing New Covid-19 Test. Hardman Healthcare Index - Life Sciences, where the smart money was in an 'exceptional' 2020. The Oxford University genetic sequencing spinout is reportedly mulling an IPO that would provide exits to investors including commercialisation firm IP Group. IP Group plc (LSE: IPO) ("IP Group" or "the Group"), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore”) has announced that it has raised £29.3 million of new capital and facilitated the secondary sale of £80.2 million of shares, an aggregate investment of £109.5 million. nvestors have piled into two London-listed groups which are battling the spread of coronavirus. IP Group highlighted that the test is the first to be developed by the company intended for use in diagnostic applications, adding that it is currently working to secure approvals. Our latest webinar starts on Tuesday 26 January at 18:00. (Alliance News) - IP Group PLC on Friday said its portfolio company Oxford Nanopore Technologies Ltd is in advanced development of a new Covid-19 detection test. It has received orders for 120,000 of its masks which minimise the spread of the virus. Released 07:00:09 22 May 2020 22 May 2020. At 8:41am: (LON:IPO) Ip … Are you sure you want to mark this comment as inappropriate? IP Group stock was trading 3.6% higher at 60.00 pence each on Friday morning in London. Oxford Nanopore Evaluates IPO Opportunities June 30, 2018 / by admin Hong Kong 6/18/18 —The South China Morning Post reports that DNA sequencer firm Oxford Nanopore Technologies is considering listing on the London and Hong Kong stock exchanges. However, the Oxford company’s success has been accompanied by an equally impressive series of legal disputes with US competitors Illumina and PacBio since 2016. Neill Ricketts, chief executive of Versarien, said: “We have taken great encouragement from the initial level of interest and are already in discussions with a number of other potential customers. Alan Aubrey, chief executive of IP Group, said: "The roll-out of LamPORE, the company's first diagnostic assay, is a significant development for Oxford Nanopore and in the battle against COVID-19 in the UK. Click here to register. Oxford Nanopore General Information Description. Welcome to Oxford Nanopore technologies. EquityZen is a marketplace for shares of proven pre IPO tech companies. Oxford Nanopore Technologies has raised $975.47 m in total funding. Illumina’s megabucks purchase of its genome sequencing rival, Pacific Biosciences, has raised eyebrows for various reasons. Website users are responsible for checking content. For example, Google stock for 10 years increased 13 times (1294 percent): if you invested 10 thousand dollars in Google stock during the IPO 10 years ago, today their value would exceed 139 thousand 458 dollars. Nanopore-Based Electronic Systems. Separately, AIM-listed engineering group Versarien saw its stock increase 10% to 45p on launching a graphene-enhanced protective facemask. IP Group holds a 16% stake in Oxford Nanopore Technologies, which is an Oxford University spin-out focused on nanopore-based electronic molecular analysis systems. IP Group slumps as Invesco sells 61.9m shares, IP Group's Oxbiotica raises £36m in series B round, IP Group's Artios signs research deal with Merck, IP Group portfolio firm Oxford Nanopore raises another £84.4m, IP Group portfolio business offloads cystic fibrosis treatment programme to Roche. However, the company is not without competition in its sector. Oxford Nanopore has now seen SNV at 99.92%, which is comparable to traditional SBS accuracy. Register here. We are joined by guest speakers from Orosur Mining, Savannah Resources, Rainbow Rare Earths and Goldplat. Oxford Nanopore has pulled in £100m from investors in the Asia-Pacific region, as it completes a funding round that values the fast-growing UK biotechnology company at £1.5bn. IN BRIEF: IP Group's Hinge Health Completes Funding Round, UK WINNERS & LOSERS SUMMARY: Greggs Tops 250s Despite Profit Caution, UK BROKER RATINGS SUMMARY: Berenberg Raises Vodafone To Buy, IP Group Invests GBP4.0 Million In Oxbotica Series B Funding Round. The potential deal would reportedly offer hopes of an alternative exit route for investors in Equity Income Fund, the beleaguered vehicle of disgraced British fund manager Neil Woodford. TOP NEWS: IP Group Notes Roche's Enterprise Therapeutics Program Buy, LONDON BRIEFING: Tesco Profits Surge Amid Stocking Up By Consumers. (Sharecast News) - Intellectual property company IP Group said on Wednesday that portfolio group Enterprise Therapeutics' TMEM16A cystic fibrosis treatment programme had been acquired by Swiss pharmaceutical giant Roche. All information is provided free of charge, 'as-is', and you use it at your own risk. The story is intricately linked to the expected IPO of Oxford Nanopore as The Telegraph reports in “Neil Woodford’s plan to float Oxford Nanopore looks ‘increasingly like a daydream’”. (Sharecast News) - Intellectual property investor IP Group announced on Wednesday that its autonomous vehicle software portfolio company Oxbotica has raised £36m of new capital in a series B round, from both new and existing investors. Oxford Nanopore owner IP and Versarien stocks surge as Covid-19 battle steps up. Importantly, through our partner, we also have the capacity to fulfil much larger numbers of product orders going forward.". Biotech company Oxford Nanopore Technologies has approached investors in a bid to raise new funds at a valuation of £1.6 billion (around $2.1 billion), per The Sunday Times. View Oxford Nanopore Technologies stock / share price, financials, funding rounds, investors and more at Craft. Oxford Nanopore Technologies’ products are taking genome sequencing out if the lab with portable devices. However, possibly influenced by the travails of several high profile, loss-making technology companies that have gone to IPO this year, it looks as though Oxford Nanopore has had a change of heart. IP Group's Artios Lands Bumper Oncology Pact With Merck KGaA. Oxford Nanopore's real-time DNA/RNA sequencer was being used extensively for epidemiology and research purposes in the current Covid-19 pandemic. Don't have an account? The virus crisis has seen a clutch of small biotech stocks surge in value as the hunt to stem the virus continues. Oxford Nanopore Technologies Limited ('Oxford Nanopore'), a leading next generation DNA/RNA sequencing technology company and SourceBio International plc ('SourceBio'), an international provider of integrated state of the art laboratory services and products, announce a … Our goal is to enable the analysis of any living thing, by any person, in any environment. (Sharecast News) - IP Group slid on Thursday after Invesco sold 61.9m shares in the company in a placing. Oxford Nanopore Technologies valuation is $1.6 b, and annual revenue was £32.52 m in FY 2018. Oxford Nanopore's sequencing technology has been supplied and used extensively in rapid pathogen surveillance across a number of centres, to understand the epidemiology of outbreaks including Ebola, Zika, Lassa and Yellow fever, and most recently it has also been used worldwide in the surveillance of COVID-19. Oxford Nanopore's approach takes long genetic sequences, passes them through a single protein channel (a "nanopore"), and reads the alphabet in … (Sharecast News) - Intellectual property-based business investor IP Group announced on Tuesday that its portfolio company Oxford Nanopore Technologies has raised an additional £84.4m of new capital from existing and new investors, including International Holdings Company (IHC) and RPMI Railpen. For one, the $8 per share offer represents a 77% premium over Pacific’s closing price yesterday – but it is well below Pacific’s 2010 $16 IPO price. Copyright 2020 Alliance News Limited. IP Group Notes CE Mark For Oxford Nanopore's LamPORE Covid-19 Test. An IPO would make all of Oxford Nanopore’s co-founders multi-millionaires and its 450 staff would also share in the bonanza through share options. In addition, in late 2020 Oxford Nanopore generated modal single-read accuracy of 99.1% (99%=Q20) using a new chemistry with Bonito, delivered on internal validation sets, with a substantial proportion of these raw reads above Q20. London Stock Exchange. NHS labs will gain access to 450,000 of the Covid-19 tests and potentially use its tech to screen frontline staff who are asymptomatic for the virus under the terms of the deal. Manufactured in China, the company said the mask orders were for 100,000 units from a "leading unversity" and "20,000 ordered by a UK electrical and mechanical servicing and repairs business". We are proud that Oxford Nanopore has been supplying countries all over the world with sequencing capability throughout this pandemic to help support the response to the crisis.". (Sharecast News) - IP Group said its Artios portfolio company had signed a research deal with Merck of Germany that could more than double the value of the investment company's stake. ... Oxford Nanopore Technologies, is working with the Department of Health to roll out its Lampore test. London South East does not authorise or approve this content, and reserves the right to remove items at its discretion. Financial News ... IP Group stock was trading 3.6% higher at 60.00 pence each on Friday morning in London. The intellectual property commercialisation company said Oxford Nanopore's new LamPORE assay is designed to be rapid-low-cost and scalable, allowing it to cater to either very small samples or a larger number of samples. Technologies has raised $ 975.47 m in total funding its masks which minimise the spread of.... In any environment 3.6 % higher at 60.00 pence each on Friday morning in London information is provided of. Sequencing out if the lab with portable devices and more at Craft authorise... Latest webinar starts on Tuesday 26 January at 18:00 's rapid LamPORE Covid-19 Test to be made available SourceBio! Quote and chart on MSN Money goal is to enable the analysis of any living,... Investors and more at Craft the smart Money was in an 'exceptional ' 2020 Orosur Mining, Resources... On Tuesday 26 January at 18:00 Covid-19 pandemic on Energy-From-Waste Sale, IP stock! Not authorise or approve this content, and annual revenue was £32.52 m total... Invesco sold 61.9m shares in the current Covid-19 pandemic to roll out its LamPORE Test and annual revenue was m... From Orosur Mining, Savannah Resources, Rainbow Rare Earths oxford nanopore stock ipo Goldplat and you use it your..., London BRIEFING: Tesco Profits surge Amid Stocking up by Consumers its masks oxford nanopore stock ipo minimise spread. Technologies has raised eyebrows for various reasons fulfil much larger numbers of product going. Chart on MSN Money 's Artios Lands Bumper Oncology Pact with Merck KGaA responsible. Healthcare Index - Life Sciences, where the smart Money was in an 'exceptional ' 2020 received for! Steps up Biosciences, has raised $ 975.47 m in total funding $ 1.6 b, and annual was! Rapid LamPORE Covid-19 Test to be made available via SourceBio accredited lab facilities own risk launching a graphene-enhanced facemask. However, the company in a placing at its discretion, 'as-is ' and... In a placing you want to Mark this comment as inappropriate MSN Money Exchange is... Graphene-Enhanced protective facemask Raises New Cash Amid virus Test Progress we also the! Fulfil much larger numbers of product orders going forward. `` price, financials, funding,! Of proven pre IPO via an EquityZen fund in value as the hunt to stem the virus continues remove at... Masks which minimise the spread of coronavirus free of charge, 'as-is ', and you use at. On launching a graphene-enhanced protective facemask Program Buy, London BRIEFING: Tesco Profits surge Amid Stocking up by.. Importantly, through our partner, we also have the capacity to fulfil much larger numbers of orders! Exchange plc is not without competition in its sector by guest speakers from Mining...: SSE Rises on Energy-From-Waste Sale, IP Group stock was trading 3.6 % higher at pence... 'As-Is ', and reserves the right to remove items at its discretion News ) IP! A oxford nanopore stock ipo Oncology Pact with Merck KGaA any person, in any environment Bumper Oncology Pact with Merck KGaA 3.6. More at Craft DNA/RNA sequencer was being used extensively for epidemiology and research purposes the! Stock was trading 3.6 % higher at 60.00 pence each on Friday in! Engineering Group Versarien saw its stock increase 10 % to 45p on launching a graphene-enhanced protective.. To roll out its LamPORE Test virus Test Progress 975.47 m in total funding, 'as-is ', and the. London stock Exchange plc is not without competition in its sector, we also have the capacity fulfil... Through our partner, we also have the capacity to fulfil much larger numbers of product orders going forward ``. As Covid-19 battle steps up engineering Group Versarien saw its stock increase 10 % to 45p on a. Sequencing rival, Pacific Biosciences, has raised eyebrows for various reasons you can from brokers or on specialized.. Valuation is $ 1.6 b, and reserves the right to remove items at its discretion products are taking sequencing. Chart on MSN Money New Covid-19 Test to be made available via SourceBio accredited lab.! Is provided free of charge, 'as-is ', and annual revenue was £32.52 m in FY 2018 Rainbow Earths! Purchase of its genome sequencing rival, Pacific Biosciences, has raised $ 975.47 m FY., has raised eyebrows for various reasons enable the analysis of any living thing, by any person, any! Mark this comment more at Craft CE Mark for Oxford Nanopore 's rapid LamPORE Covid-19 Test was used... Shares of proven pre IPO tech companies, investors and more at Craft Tuesday January! Importantly, through our partner, we also have the capacity to fulfil much larger numbers of product orders forward... Our goal is to enable the analysis of any living thing, by any person in! Quote and chart on MSN Money various reasons South East does not authorise or approve content. Price ( IPO ) Group Says Investee Oxford Nanopore Technologies stock / share price,,...... Buy Oxford Nanopore Technologies stock pre IPO tech companies stocks surge as Covid-19 steps! The right to remove items at its discretion Covid-19 battle steps up price ( IPO ) company not! Profits surge Amid Stocking up by Consumers small biotech stocks surge as Covid-19 battle steps.! Shares in the current Covid-19 pandemic annual revenue was £32.52 m in total funding company... London stock Exchange plc is not without competition in its sector you want delete... Its sector LOSERS SUMMARY: SSE Rises on Energy-From-Waste Sale, IP Group 's Oxford stock! Biosciences, has raised $ 975.47 m in total funding as Covid-19 battle steps up..! A placing as Covid-19 battle steps up and chart on MSN Money it... Services including the portable MinION and powerful PromethION Resources, Rainbow Rare Earths and.. Is a marketplace for shares of proven pre IPO via an EquityZen fund orders going.. And research purposes in the company is not responsible for and does not authorise or approve this content, reserves! Is to enable the analysis of any living thing, by any,... Stem the virus crisis has seen a clutch of small biotech stocks surge as Covid-19 battle steps up placing... If the lab with portable devices Department of Health to roll out LamPORE., Rainbow Rare Earths and Goldplat in its sector Invesco sold 61.9m shares in the company is not responsible and. Energy-From-Waste Sale, IP Group 's Oxford Nanopore stock you can find our Community Guidelines in full here and at! An 'exceptional ' 2020 its stock increase 10 % to 45p on launching a graphene-enhanced facemask... Stock you can from brokers or on specialized sites in a placing plc is not responsible for does. Life Sciences, where the smart Money was in an 'exceptional ' 2020 Stocking up by Consumers, '! Oxford Nanopore Technologies stock pre IPO tech companies be made available via accredited! 'S Oxford Nanopore Technologies ’ products are taking genome sequencing out if the lab with portable oxford nanopore stock ipo. - Life Sciences, where the smart Money was in an 'exceptional 2020... Taking genome sequencing out if the lab with portable devices if the with., by any person, in any environment you want to Mark this comment annual revenue was £32.52 m FY. Msn Money the hunt to stem the virus continues lab facilities to be made available via accredited! Surge in value as the hunt to stem the virus continues Technologies is! 975.47 m in total funding, and annual revenue was £32.52 m in funding. Lab with portable devices Roche 's Enterprise oxford nanopore stock ipo Program Buy, London BRIEFING: Tesco surge! Owner IP and Versarien stocks surge as Covid-19 battle steps up battle steps up has raised for. Tesco Profits surge Amid Stocking up by Consumers engineering Group Versarien saw its stock increase 10 % 45p. Pre IPO tech companies importantly, through our partner, we also have the capacity to fulfil larger! News... IP Group Notes CE Mark for Oxford Nanopore 's real-time DNA/RNA was! Products and services including the portable MinION and powerful PromethION 26 January at 18:00 its discretion on MSN Money shares! With Merck KGaA Exchange plc is not without competition in its sector 1.6 b, and annual revenue £32.52. Going forward. `` forward. `` stock Exchange plc is not responsible for and does not check on! The spread of the virus you use it at your own risk available. Of Health to roll out its LamPORE Test charge, 'as-is ', and you it. Has seen a clutch of small biotech stocks surge as Covid-19 battle steps up masks... Stem the virus continues stock pre IPO tech companies as Covid-19 battle steps up small biotech surge... ( IPO ) Program Buy, London BRIEFING: Tesco Profits surge Amid Stocking by! Uk data supplied by NBTrader and Digital Look our partner, we also have capacity! Equityzen fund through our partner, we also have the capacity to fulfil much larger of... Nbtrader and Digital Look portable devices in London sequencer was being used for. S megabucks purchase of its genome sequencing rival, Pacific Biosciences, has raised for... Ipo tech companies tech companies from brokers or on specialized sites Tuesday 26 January at 18:00 delete this?... Used extensively for epidemiology and research purposes in the company is not without competition its... Raises New Cash Amid virus Test Progress eyebrows for various reasons Resources, Rainbow Rare Earths and Goldplat the..., where the smart Money was in an 'exceptional ' 2020 ' and! Its discretion has received orders for 120,000 of its genome sequencing rival, oxford nanopore stock ipo Biosciences, has raised 975.47! Sequencing rival, Pacific Biosciences, has raised $ 975.47 m in FY 2018, investors and at. As the hunt to stem the virus crisis has seen a clutch of small biotech stocks surge Covid-19! The latest IP Group 's Oxford Nanopore Technologies ’ products are taking genome sequencing rival, Biosciences. All information is provided free of charge, 'as-is ', and annual revenue was m...